CDTX vs COF · rev $1.3M vs P/E 62, rev $53.43B
Cidara Therapeutics Inc (CDTX) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
CDTX currently screens at market cap $6.96B. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the CDTX and COF stock pages for the full models.
Not investment advice.